Diarrhea Clinical Trial
Official title:
Effect of Drinking Water Chlorination on Child Survival in Rural Kenya
NCT number | NCT04020965 |
Other study ID # | 1903034 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 26, 2019 |
Est. completion date | May 26, 2021 |
Verified date | September 2022 |
Source | Tufts University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to estimate the effect of community-wide provision of water treatment (chlorine) solution on all-cause child mortality and on infectious disease related child mortality. We will also examine effects on the following secondary outcomes: 7-day diarrhea prevalence, all-cause under-2 mortality, diarrheal disease related child mortality, school attendance, and school enrollment. In addition, and for a subsample of children, we will examine effects on motor development, emergent language and literacy, emergent math/numeracy, and socio-emotional development.
Status | Completed |
Enrollment | 46212 |
Est. completion date | May 26, 2021 |
Est. primary completion date | May 26, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A to 50 Years |
Eligibility | Inclusion Criteria: 1. Had one or more live births since January 1, 2008. 2. Live in a village which was randomized to water treatment or control arms during the WASH Benefits Kenya trial. |
Country | Name | City | State |
---|---|---|---|
Kenya | REMIT Kenya | Kisumu |
Lead Sponsor | Collaborator |
---|---|
Tufts University | University of California, Berkeley, University of Chicago |
Kenya,
Bhalotra, S. R., Díaz-Cayeros, A., Miller, G., Miranda, A. & Venkataramani, A. S. Urban Water Disinfection and Mortality Decline in Developing Countries.
Cutler D, Miller G. The role of public health improvements in health advances: the twentieth-century United States. Demography. 2005 Feb;42(1):1-22. — View Citation
Galiani, S., Gertler, P. & Schargrodsky, E. Water for Life: The Impact of the Privatization of Water Services on Child Mortality. J. Polit. Econ. 113, 83-120 (2005).
World Health Organization. Drinking-water. Available at: https://www.who.int/news-room/fact-sheets/detail/drinking-water. (Accessed: 20th February 2019)
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | All-cause under-five child mortality | All-cause mortality for children who died under the age of 5 years. | Measured 6 years after start of intervention (recall period from start of intervention to day of survey) | |
Primary | Infectious disease related under-five child mortality | Mortality for children who died under the age of 5 years from infectious or parasitic diseases. Based on the 2016 WHO Verbal Autopsy instrument, the category of deaths by "infectious and parasitic diseases" include the following causes (ICD-10 codes in parenthesis):
Sepsis (A41) Acute respiratory infection, including pneumonia (J22/J18) HIV/AIDS related death (B24) Diarrheal diseases (A09) Malaria (B54) Measles (B05) Meningitis and encephalitis (G03; G04) Tetanus, excluding neonatal tetanus (A35) Pulmonary tuberculosis (A16) Pertussis (A37) Hemorrhagic fever (A99) Dengue fever (A90; A91) Unspecified infectious disease (B99) |
Measured 6 years after start of intervention (recall period from start of intervention to day of survey) | |
Secondary | 7-day under-five child diarrhea prevalence | Diarrhea is defined as 3+ loose or watery stools in a 24 hour period. Data will be measured in interviews using mother-reported symptoms with a 7-day recall among children under 5 years. | Measured 6 years after intervention start | |
Secondary | All-cause under-two mortality | All-cause mortality for children who died under the age of 2 years. | Measured 6 years after intervention (recall period from start of intervention to day of survey) | |
Secondary | Diarrheal disease related under-five child mortality | Mortality for children who died under the age of 5 years from diarrheal disease (ICD-10 code A09). | Measured 6 years after intervention (recall period from start of intervention to day of survey) | |
Secondary | School attendance | Mother-reported school attendance on the day of the survey | Measured 6 years after intervention start | |
Secondary | School enrollment | Mother-reported school enrollment at the time of the survey | Measured 6 years after intervention start | |
Secondary | Motor development | Motor development measured with the International Development and Early Learning Assessment tool. | Measured 6 years after intervention start | |
Secondary | Emergent language and literacy | Emergent language and literacy measured with the International Development and Early Learning Assessment tool. | Measured 6 years after intervention start | |
Secondary | Emergent math/numeracy | Emergent math/numeracy measured with the International Development and Early Learning Assessment tool. | Measured 6 years after intervention start | |
Secondary | Socio-emotional development | Socio-emotional development measured with the International Development and Early Learning Assessment tool. | Measured 6 years after intervention start | |
Secondary | All-cause under-six months mortality | All-cause mortality for children who died under the age of 6 months. | Measured 6 years after intervention (recall period from start of intervention to day of survey) | |
Secondary | All-cause neonatal mortality | All-cause mortality for children who died under the age of 4 weeks. | Measured 6 years after intervention (recall period from start of intervention to day of survey) | |
Secondary | Infectious disease related under-two mortality | Mortality for children who died under the age of 2 years from infectious or parasitic diseases. Based on the 2016 WHO Verbal Autopsy instrument, the category of deaths by "infectious and parasitic diseases" include the following causes (ICD-10 codes in parenthesis): | Measured 6 years after start of intervention (recall period from start of intervention to day of survey) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06283784 -
Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients
|
N/A | |
Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
Completed |
NCT04003181 -
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
|
N/A | |
Completed |
NCT03596827 -
The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection
|
N/A | |
Recruiting |
NCT05372068 -
Cement flooRs AnD chiLd hEalth (CRADLE)
|
N/A | |
Completed |
NCT03972618 -
Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic
|
N/A | |
Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
Not yet recruiting |
NCT05052489 -
Registry and Clinical Observation of Children With Diarrhoeal Disease
|
||
Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
Completed |
NCT02428647 -
Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT01968408 -
Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
|
Phase 3 | |
Completed |
NCT01739231 -
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
|
Phase 1/Phase 2 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Terminated |
NCT01472211 -
Water-based Zinc Intervention Trial in Zinc Deficient Children
|
Phase 0 | |
Completed |
NCT01371656 -
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
|
Phase 3 | |
Not yet recruiting |
NCT01382199 -
Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
|
Phase 3 | |
Terminated |
NCT01048567 -
Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly
|
Phase 2 | |
Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
Completed |
NCT00760851 -
Yogurt Study in Children 2-4 Years Old Attending Daycare
|
Phase 3 |